发明名称 Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues
摘要 Ophthalmically therapeutic materials, such as liquid-containing compositions and polymeric drug delivery systems, include a therapeutic component that includes an Glucocorticoid Derivative which, upon delivery to the posterior segment of a mammalian eye, does not significantly diffuse to the anterior segment of said eye. Methods of making and using the present materials are also described.
申请公布号 US9259429(B2) 申请公布日期 2016.02.16
申请号 US201414463034 申请日期 2014.08.19
申请人 Allergan, Inc. 发明人 Edelman Jeffrey L.;Harrison Kelly M.
分类号 A61K31/74;A61K31/573;A61K9/00;A61K31/56;A61K9/16;A61K31/728;A61K47/36 主分类号 A61K31/74
代理机构 代理人 Phan Brigitte C.
主权项 1. A method of treating macular edema of a mammalian eye comprising periocular administration of a composition comprising a therapeutically effective amount of hyaluronic acid and a glucocorticoid derivative comprising an acyl group linked to C17 via an ester linkage.
地址 Irvine CA US